SecBot SecBot

BPTH

BIO-PATH HOLDINGS, INC.
OTC· Pharmaceutical Preparations· Inc. DE· CIK 0001133818 Biotech & Drug Discovery
$0.000300 +0.00 (+0.00%)
Oct 23 4:00 PM ET · prev $0.000300
1 year
−99.7%
from $0.0998 · Oct 27
30 days
−40.0%
from $0.000500
52-week range
$0.00010000–0.0998
−100% from high · low Sep 11
Avg volume 20D
14.0K
Oct 2 spike 198.7K
Short interest
2.4K
0.0%
Days to cover
1.0
at average volume
New fund stakes
0
Q4 2024 13F · 0 exits
Filing reports
3
analyzed by SecBot
SecBot read BEARISH 1 report · latest
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/1
Strongest BEARISH Bio-Path Holdings is executing a radical pivot from a cash-strapped biotech to a crypto-focused digital…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q4 2024: 1 added (0 new), 0 trimmed or exited.

  • Short sellersSTEADY

    Short interest 0.0% to 2.4K shares. 1.0 days to cover.

  • TrendRANGE

    98% below its 50-day average.

Who's buying

13F· Q4 2024
0
new positions
0
exits
FundMoveSharesValue
BANK OF AMERICA CORP /DE/ADD43$50.00
BANK OF AMERICA CORP /DE/TRIM27$24.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Jul 2024
Recent actions
DateFirmActionRating
Jul 8, 2024Roth MKM
REITERATE
REITERATEBuy
Apr 18, 2024Roth MKM
REITERATE
REITERATEBuy
Mar 27, 2024Roth MKM
MAINTAIN
MAINTAINBuy

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Aug 12, 2026
Earnings date
BPTH Q2 2026 Earnings Scheduled — 2026-08-12
May 13, 2026
Earnings date
BPTH Q1 2026 Earnings Scheduled — 2026-05-13
Apr 17, 2026
Earnings date
BPTH Q4 2025 Earnings After Market Close — 2026-04-17
Apr 15, 2026
Earnings date
BPTH Q4 2025 Earnings After Market Close — 2026-04-15
Mar 25, 2026
Earnings date
BPTH Q4 2025 Earnings After Market Close — 2026-03-25

Short side

FINRA· Sep 30, 2026
2,365
shares short
0.0%
vs prior settlement
1.0
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 12, 2026 Earnings calendar
BPTH Q2 2026 Earnings Scheduled — 2026-08-12
Jul 16, 2026 SEC
Bio-Path Holdings is executing a radical pivot from a cash-strapped biotech to a crypto-focused digital asset treasury…
8-K — Impact 7/10
May 26, 2026 SEC
Bio-Path is abandoning its pharmaceutical focus to launch a Digital Asset Treasury 2.0 (DAT 2.0) using AI for crypto…
8-K — Impact 7/10
Feb 24, 2026 SEC
Bio-Path Holdings issued Series S Preferred stock and warrants to its CEO's advisory firm, canceled a planned reverse…
8-K — Impact 6/10
Dec 31, 2024 Inst.
BANK OF AMERICA CORP — ADD
43 shares ($50.00)
Sep 30, 2024 Inst.
BANK OF AMERICA CORP — TRIM
27 shares ($24.00)

SecBot reports

3 filings · 0 bullish · 2 bearish · 1 mixed
All BPTH filing & press-release reports (3)